2027 ICD-10-CM Diagnosis Code D68.32Hemorrhagic disorder due to extrinsic circulating anticoagulants
ICD-10-CM Codes›D50–D89›D65-D69›D68
- Billable — Valid for Submission
- CC — Complication or Comorbidity
- Chronic Condition
D68.32 is a billable ICD-10-CM diagnosis code for hemorrhagic disorder due to extrinsic circulating anticoagulants. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 813. As a secondary diagnosis, it counts as a complication or comorbidity (CC) and moves an inpatient stay to a higher severity level within its MS-DRG family. It does not count, however, when the principal diagnosis is one of 51 closely related codes. Coders also document this condition as acquired coagulation factor inhibitor disorder. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Coagulation and hemorrhagic disorders.
D68.32 no longer risk-adjusts for Medicare Advantage: it mapped to HCC 48 under the retired CMS-HCC V24 model through payment year 2025 but maps to no category in the live V28 model. It still risk-adjusts in the PACE (CMS-HCC V22) category 48, ESRD (V21) category 48, and ESRD (V24) category 48 for payment year 2027.
Code Identity
Code Classification
Medicare Risk Adjustment (HCC)Billing
D68.32 no longer risk-adjusts for Medicare Advantage: it maps to no payment category in the live CMS-HCC V28 model, although it still risk-adjusts in the other CMS models shown below.
Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Acquired coagulation factor inhibitor disorder
- Anticoagulant-induced bleeding
- Drug-induced coagulation inhibitor disorder
- Factor V inhibitor disorder
- Hemorrhagic disorder due to circulating anticoagulants
- Hemorrhagic disorder due to hyperheparinemia
- Hemorrhagic disorder due to increase in anti-10a
- Hyperheparinemia
Instructional NotesGuidance
Instructions from the official ICD-10-CM Tabular List that apply to D68.32: its own notes plus those printed at D68 and Chapter 3. A note printed at a category, block or chapter applies to every code under it.
Applicable To
Conditions this code is used for: synonyms of the title or, for "other specified" codes, the conditions assigned to it. The list is not exhaustive.
- Drug-induced hemorrhagic disorder
- Hemorrhagic disorder due to increase in anti-IIa
- Hemorrhagic disorder due to increase in anti-Xa
- Hyperheparinemia
Excludes1
Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.
Excludes2
Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Use Additional Code
Add a second code, after this one, to fully describe the condition.
Source: CMS ICD-10-CM Tabular List. How to read instructional notes.
Referenced in Other NotesGuidance
Instructional notes printed at other codes that name D68.32, its category, or a range that includes it.
Excludes1 1
These codes carry an Excludes1 note naming D68.32: they are not reported together with it, unless the two conditions are unrelated.
Excludes2 1
These codes carry an Excludes2 note naming D68.32: its condition is not part of those codes, and both may be reported when the patient has both.
- Block R70-R79 Abnormal findings on examination of blood, without diagnosis
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Anticoagulant, circulating (intrinsic) See Also: - Disorder, hemorrhagic; D68.318
drug-induced (extrinsic) See Also: - Disorder, hemorrhagic; D68.32
iatrogenic D68.32
Circulating anticoagulants See Also: - Disorder, hemorrhagic; D68.318
due to drugs See Also: - Disorder, hemorrhagic; D68.32
Disorder (of) See Also: Disease;
drug induced hemorrhagic D68.32
drug-induced D68.32
Hyperheparinemia D68.32
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Bleeding Disorders
Normally, if you get hurt, your body forms a blood clot to stop the bleeding. For blood to clot, your body needs cells called platelets and proteins known as clotting factors. If you have a bleeding disorder, you either do not have enough platelets or clotting factors or they don't work the way they should.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D68.32 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About D68.32Overview
What is the ICD-10 code for hemorrhagic disorder due to extrinsic circulating anticoagulants?
The ICD-10-CM code for hemorrhagic disorder due to extrinsic circulating anticoagulants is D68.32 (sometimes written as D6832). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
Is D68.32 (Hemorrhagic disorder due to circulating anticoagulants) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report hemorrhagic disorder due to extrinsic circulating anticoagulants on HIPAA-covered claims from October 1, 2026 through September 30, 2027.
What MS-DRG does D68.32 group to?
When hemorrhagic disorder due to extrinsic circulating anticoagulants is the principal diagnosis on an inpatient stay, it groups to MS-DRG 813 (coagulation Disorders), which carries a relative weight of 1.5279. Higher weights mean higher Medicare reimbursement.
Is D68.32 a CC or MCC?
CMS lists D68.32 as a CC (complication or comorbidity) for FY 2027. Reported as a secondary diagnosis, it moves the inpatient stay to a higher-weighted DRG within its severity family. It does not count when the principal diagnosis is one of the 51 closely related codes in its exclusion list.
Can D68.32 be reported with R79.1?
Not as a rule. The Excludes1 note at D68, which applies to D68.32, lists "abnormal coagulation profile NOS (R79.1)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).
Does D68.32 risk-adjust for Medicare Advantage payment?
Not for Medicare Advantage. D68.32 mapped to HCC 48 in the retired CMS-HCC V24 model, which last determined payment in 2025, but it maps to no category in the live V28 model; see all codes that no longer risk-adjust. It still risk-adjusts in the PACE (CMS-HCC V22) category 48 (Coagulation Defects and Other Specified Hematological Disorders), ESRD (V21) category 48 (Coagulation Defects and Other Specified Hematological Disorders), and ESRD (V24) category 48 (Coagulation Defects and Other Specified Hematological Disorders).
